Reviva Pharmaceuticals Holdings Stock Filter Stocks by Fundamentals
RVPH Stock | USD 1.43 0.09 6.72% |
Reviva Pharmaceuticals Holdings fundamentals help investors to digest information that contributes to Reviva Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Reviva Stock. The fundamental analysis module provides a way to measure Reviva Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Reviva Pharmaceuticals stock.
Reviva | Shares Owned by Institutions |
Reviva Pharmaceuticals Current Valuation Drivers
We derive many important indicators used in calculating different scores of Reviva Pharmaceuticals from analyzing Reviva Pharmaceuticals' financial statements. These drivers represent accounts that assess Reviva Pharmaceuticals' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Reviva Pharmaceuticals' important valuation drivers and their relationship over time.
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Market Cap | 26.8M | 42.7M | 82.9M | 122.6M | 110.3M | 115.8M | |
Enterprise Value | 18.0M | 13.1M | 64.4M | 99.2M | 89.3M | 93.7M |
Reviva Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Reviva Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Reviva Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Reviva Pharmaceuticals' value.Shares | |||
Group One Trading, Lp | 2024-09-30 | 75.6 K | |
The Colony Group Llc | 2024-12-31 | 60 K | |
H D Vest Advisory Services | 2024-12-31 | 60 K | |
Northern Trust Corp | 2024-12-31 | 56.6 K | |
Ameriprise Financial Inc | 2024-12-31 | 46.5 K | |
Emc Capital Management(tx) | 2024-12-31 | 44.5 K | |
Engineers Gate Manager Lp | 2024-12-31 | 34.6 K | |
Sound Income Strategies | 2024-12-31 | 30 K | |
Tower Research Capital Llc | 2024-12-31 | 26.8 K | |
Millennium Management Llc | 2024-12-31 | 1.8 M | |
Vanguard Group Inc | 2024-12-31 | 1.4 M |
Reviva Fundamentals
Return On Equity | -17.95 | ||||
Return On Asset | -3.28 | ||||
Current Valuation | 56.94 M | ||||
Shares Outstanding | 46.58 M | ||||
Shares Owned By Insiders | 14.34 % | ||||
Shares Owned By Institutions | 29.45 % | ||||
Number Of Shares Shorted | 4.25 M | ||||
Price To Book | 8.35 X | ||||
EBITDA | (39.5 T) | ||||
Net Income | (39.26 M) | ||||
Cash And Equivalents | 23.19 M | ||||
Cash Per Share | 1.13 X | ||||
Total Debt | 17.98 M | ||||
Current Ratio | 6.72 X | ||||
Book Value Per Share | (0.30) X | ||||
Cash Flow From Operations | (28.32 M) | ||||
Short Ratio | 2.51 X | ||||
Earnings Per Share | (1.08) X | ||||
Target Price | 12.14 | ||||
Number Of Employees | 15 | ||||
Beta | -0.12 | ||||
Market Capitalization | 66.61 M | ||||
Total Asset | 23.7 M | ||||
Retained Earnings | (134.35 M) | ||||
Working Capital | 6.53 M | ||||
Net Asset | 23.7 M |
About Reviva Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Reviva Pharmaceuticals Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Reviva Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Reviva Pharmaceuticals Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out Reviva Pharmaceuticals Piotroski F Score and Reviva Pharmaceuticals Altman Z Score analysis. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.